Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Wilms Tumor × Data Collection × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 13 Pancreatic Neoplasms 5 Breast Neoplasms 5 Ovarian Neoplasms 3 Multiple Myeloma 3 Lymphoma 3 Uterine Cervical Neoplasms 2 Thyroid Diseases 2 Prostatic Neoplasms 2 Pancreatic Cyst 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Hairy Cell 2 Leukemia 2 Hematologic Neoplasms 2 Endometrial Neoplasms 2 Wilms Tumor 1 Venous Thrombosis 1 Venous Thromboembolism 1 Uveal Melanoma 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Thrombosis 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

Filgrastim 8 Cyclophosphamide 8 Granulocyte Colony-Stimulating Factor 6 Melphalan 5 Busulfan 5 Vincristine 4 Temozolomide 4 Stem Cell Transplantation 4 Peripheral Blood Stem Cell Transplantation 4 Etoposide 4 fludarabine 3 Topotecan 3 Mesna 3 Ifosfamide 3 Doxorubicin 3 Cisplatin 3 sargramostim 2 fludarabine phosphate 2 Thiotepa 2 Therapeutics 2 Sirolimus 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Nivolumab 2 Itraconazole 2 Drug Therapy 2 Bone Marrow Transplantation 2 Blood Specimen Collection 2 trioctyl phosphine oxide 1 thymoglobulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04423484 2026-03-02

GFANEPHRO20

French Africa Pediatric Oncology Group

Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡